Startek Reports Fourth Quarter and Full Year 2021 Financial Results
Startek, Inc. (NYSE:SRT) ("Startek" or the "Company"), a global customer experience (CX) solutions provider, is reporting financial results for the fourth quarter and full year ended December 31, 2021.
Fourth Quarter 2021 Financial Summary ($ in millions, excl. margin items)
|
|
Q4 2021 |
|
Q4 2020 |
|
Change |
||||||
Net Revenue |
|
$ |
178.7 |
|
|
$ |
174.5 |
|
|
|
2 |
% |
Gross Profit |
|
$ |
26.8 |
|
|
$ |
30.2 |
|
|
|
(11 |
)% |
Gross Margin |
|
|
15 |
% |
|
|
17.3 |
% |
|
-230 |
bps |
|
SG&A Expenses |
|
$ |
15.1 |
|
|
$ |
14.7 |
|
|
|
3 |
% |
Net Income/(Loss)[1] |
|
$ |
6.7 |
|
|
$ |
(7.6 |
) |
|
|
188 |
% |
EPS[1] |
|
$ |
0.16 |
|
|
$ |
(0.19 |
) |
|
|
184 |
% |
Adjusted Net Income/(Loss)[2], [3] |
|
$ |
12.9 |
|
|
$ |
8.8 |
|
|
|
47 |
% |
Adjusted EPS[2], [3] |
|
$ |
0.32 |
|
|
$ |
0.22 |
|
|
|
45 |
% |
Adjusted EBITDA[3] |
|
$ |
18.9 |
|
|
$ |
23.3 |
|
|
|
(19 |
)% |
Full Year 2021 Financial Summary ($ in millions, excl. margin items)
|
|
2021 |
|
2020 |
|
Change |
||||||
Net Revenue |
|
$ |
703.6 |
|
|
$ |
640.2 |
|
|
|
10 |
% |
Gross Profit |
|
$ |
97.6 |
|
|
$ |
87.2 |
|
|
|
12 |
% |
Gross Margin |
|
|
13.9 |
% |
|
|
13.6 |
% |
|
30 |
bps |
|
SG&A Expenses |
|
$ |
54.6 |
|
|
$ |
59.7 |
|
|
|
(9 |
)% |
Net Income/(Loss)[1] |
|
$ |
1.5 |
|
|
$ |
(39.0 |
) |
|
|
104 |
% |
EPS[1] |
|
$ |
0.04 |
|
|
$ |
(0.99 |
) |
|
|
104 |
% |
Adjusted Net Income/(Loss)[2], [3] |
|
$ |
27.3 |
|
|
$ |
8.5 |
|
|
|
221 |
% |
Adjusted EPS[2], [3] |
|
$ |
0.67 |
|
|
$ |
0.22 |
|
|
|
205 |
% |
Adjusted EBITDA[3] |
|
$ |
72.4 |
|
|
$ |
58.2 |
|
|
|
24 |
% |
|
|
|
|
|
|
|
|
|
|
[1] Reflects net income (loss) attributable to Startek shareholders.
[2] Reflects Adjusted net income (loss) attributed to Startek shareholders.
[3] Refer to the note below about Non-GAAP financial measures.
Management Commentary
“During the fourth quarter, we continued to support our growth across core verticals and meaningfully enhance our operational foundation,” said Bharat Rao, Global CEO of Startek. “We generated year-over-year revenue growth for both the fourth quarter and full year, while maintaining our disciplined approach to cost management across the business. Since assuming the helm of our executive leadership team in October 2021, I’ve spent a considerable amount of time meeting with our management teams across the globe, along with many of our client accounts and stakeholders, to evaluate how we are performing relative to expectations.
“Throughout this initial evaluation period, we have already made significant changes across the organization. On an operational level, we continued to invest in our technological capabilities, especially in cybersecurity, to ensure that we remain protected against future threats and fully optimize the dexterity of our services. We also greatly bolstered our leadership team, adding five new executives, including myself, since October 2021 to round out our C-suite. With a strong focus on accelerating profitable growth, while providing our clients a best-in-class, digital-first customer experience, we now have an executive team that is fully aligned on the mission at-hand going forward.
“As we progress through 2022, we’re going to continue making meaningful investments to drive growth. We’ve already started building out a revamped sales infrastructure with a reorganized lead generation team, and we anticipate adding additional senior sales leaders over the next few months. To further support our sales process, our marketing team has been at work better defining our overall value proposition to customers and implementing more effective go-to-market strategies. We will also continue to have a disciplined approach with our cost structure. In fact, through a detailed analysis, we have been identifying centers with sub-optimal performance to evaluate the necessary consolidation or right-sizing actions to improve the overall utilization of our footprint.
“Our work to optimize our cost structure, build out our leadership team, and refine our sales and marketing focus has positioned us to further enhance our omni-channel capabilities and execute on our growth initiatives in 2022. I am incredibly proud of our team’s sustained commitment to providing best-in-class service to our customers during this time of evaluation and transition. I have the utmost confidence in our bolstered organizational structure to begin accelerating on our growth trajectory.”
Fourth Quarter 2021 Financial Results
Net revenue in the fourth quarter increased slightly to $178.7 million compared to $174.5 million in the year-ago quarter. The increase was attributable to continued solid performance within the Company’s core verticals and geographies. On a constant currency basis, net revenue increased 2.2% compared to the prior year period.
Gross profit in the fourth quarter was $26.8 million compared to $30.2 million in the year-ago quarter. Gross margin was 15% compared to 17.3% in the year-ago quarter. The decrease was primarily due to the impact of a one-off performance bonus declared in December 2021 and continued growth in the telecom and government verticals that are delivered onshore, partially offset by the Company’s sustained commitment to prudent cost management across the organization.
Selling, general and administrative (SG&A) expenses in the fourth quarter were $15.1 million compared to $14.7 million in the year-ago quarter. As a percentage of revenue, SG&A was the same at 8.4% compared to the year-ago quarter. The increase was driven by the investments in sales, marketing and digital teams where the Company added new positions to strengthen its go-to-market efforts.
Net income attributable to Startek shareholders in the fourth quarter increased significantly $6.7 million or $0.16 per share, compared to a net loss of $7.6 million or $(0.19) per share in the year-ago quarter. The net income in the current period included a $6.7 million impact of fair value gains from the investment in CSS Corp. that was partially offset by an approximate $4.5 million impairment charge on right-of-use assets related to operating leases in select geographies where the Company’s client service is pivoting towards at-home delivery.
Adjusted net income* in the fourth quarter was $12.9 million or $0.32 per diluted share, compared to adjusted net income* of $8.8 million or $0.22 per diluted share in the year-ago quarter.
Adjusted EBITDA* in the fourth quarter was $18.9 million compared to $23.3 million in the year-ago quarter. The decrease was primarily driven by the aforementioned lower levels of gross profit and incremental investments in SG&A during the quarter.
At December 31, 2021, cash and restricted cash were $55.4 million[1] compared to $63.5 million at September 30, 2021. The decrease was due to the lower level of working capital generated during the fourth quarter relative to the third quarter of 2021. Total debt at December 31, 2021 was $170.0 million compared to $170.4 million at September 30, 2021, and net debt at December 31, 2021 was $114.6 million[2] compared to $106.9 million at September 30, 2021.
During the three months ended December 31, 2021, the Company repurchased an aggregate of 353,810 shares of common stock under its repurchase plan, at an average cost of $4.44 per share.
Full Year 2021 Financial Results
Net revenue in 2021 increased 10% to $703.6 million compared to $640.2 million in 2020. This increase was primarily due to strong performance and recovery trends across core verticals, including the additional revenue generated from the U.S. COVID-19 assistance government contract in the second quarter of 2021. On a constant currency basis, net revenue increased 10.6% compared to the prior year.
Gross profit in 2021 increased 12% to $97.6 million compared to $87.2 million in 2020. Gross margin increased 30 basis points to 13.9% compared to 13.6% in 2020. The increase was primarily due to the recovery and growth trends across several core verticals, including the increased revenue from the healthcare and education vertical as a result of the aforementioned vaccine program in the second quarter. The increase was also supported by lower rental costs in 2021 relative to 2020 due to favorable renegotiations during lease contract renewals.
Selling, general and administrative (SG&A) expenses in 2021 decreased to $54.6 million compared to $59.7 million in 2020. As a percentage of revenue, SG&A improved 150 basis points to 7.8% compared to 9.3% in 2020 as a result of the Company’s higher revenue base and lower communication and maintenance expenses.
Net income to Startek shareholders in 2021 improved to $1.5 million or $0.04 per share, compared to a net loss of $(39.0) million or $(0.99) per share in 2020. Net income in 2021 included a one-time charge related to expenses associated with the debt refinancing the Company completed in February 2021, as well as the aforementioned approximate $4.5 million in impairment charges recorded in the fourth quarter of 2021. Net loss in 2020 included an approximate $35.9 million goodwill impairment charge accounted in the first quarter and in the fourth quarter due to COVID-19 related forecasted declines in the Company’s business in India, South Africa, Australia and Argentina, owing primarily to the devaluation of the local currency.
Adjusted net income* in 2021 increased significantly to $27.3 million or $0.67 per diluted share, compared to adjusted net income* of $8.5 million or $0.22 per diluted share in 2020.
Adjusted EBITDA* in 2021 increased 24% to $72.4 million compared to $58.2 million in 2020. The increase is due to the aforementioned revenue growth and cost reductions driven during the year.
During the year ended December 31, 2021, the Company repurchased an aggregate of 412,769 shares of its common stock under its repurchase plan, at an average cost of $4.61 per share.
*A non-GAAP measure defined below.
[1] Cash balance excluding restricted cash at December 31, 2021 amounted to $47.9 million as compared to $56.8 million at September 30, 2021.
[2] Net debt excluding restricted cash balance at December 31, 2021 was $122.1 million compared to $113.6 million at September 30, 2021.
Conference Call and Webcast Details
Startek management will hold a conference call today at 5:00 p.m. Eastern time to discuss its financial results. The conference call will be followed by a question and answer period.
Date: Thursday, March 10, 2022
Time: 5:00 p.m. Eastern Time
Toll-free dial-in number: (844) 239-5283
International dial-in number: (574) 990-1022
Conference ID: 5348066
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at (949) 574-3860.
The conference call will be broadcast live and available for replay here, as well as in the investor relations section of the company’s website at www.startek.com.
A telephonic replay of the conference call will also be available after 8:00 p.m. Eastern time on the same day through March 17, 2022.
Toll-free replay number: (855) 859-2056
International replay number: (404) 537-3406
Replay ID: 5348066
About Startek
Startek is a global provider of tech-enabled business process management solutions. The company provides omni-channel customer experience, digital transformation, and technology services to some of the finest brands globally. Startek is committed to impacting clients’ business outcomes by focusing on enhancing customer experience and digital & AI enablement across all touch points and channels. Startek has more than 45,000 CX experts spread across 45 delivery campuses in 13 countries. The company services over 200 clients across a range of industries such as banking and financial services, insurance, technology, telecom, healthcare, travel & hospitality, ecommerce, consumer goods, retail, and energy & utilities. To learn more about Startek’s global solutions, please visit www.startek.com.
Forward-Looking Statements
The matters regarding the future discussed in this news release include forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are intended to be identified in this document by the words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. As described below, such statements are subject to a number of risks and uncertainties that could cause Startek's actual results to differ materially from those expressed or implied by any such forward-looking statements. Readers are encouraged to review risk factors and all other disclosures appearing in the Company's Form 10-K, as well as other filings with the Securities and Exchange Commission (SEC), for further information on risks and uncertainties that could affect Startek's business, financial condition and results of operation. Copies of these filings are available from the SEC, the Company’s website or the Company’s investor relations department. Startek assumes no obligation to update or revise any forward-looking statements as a result of new information, future events or otherwise. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date herein.
STARTEK, INC. AND SUBSIDIARIES Condensed Consolidated Statements of Income (loss) (In thousands, except per share amounts) |
||||||||||||||||
|
|
Three Months Ended December |
|
Year Ended December |
||||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Revenue |
|
|
177,667 |
|
|
|
174,918 |
|
|
|
703,546 |
|
|
|
641,844 |
|
Warrant contra revenue |
|
|
1,078 |
|
|
|
(449 |
) |
|
|
87 |
|
|
|
(1,622 |
) |
Net revenue |
|
|
178,745 |
|
|
|
174,469 |
|
|
|
703,633 |
|
|
|
640,222 |
|
Cost of services |
|
|
(151,907 |
) |
|
|
(144,227 |
) |
|
|
(606,031 |
) |
|
|
(552,973 |
) |
Gross profit |
|
|
26,838 |
|
|
|
30,242 |
|
|
|
97,602 |
|
|
|
87,249 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Selling, general and administrative expenses |
|
|
(15,075 |
) |
|
|
(14,712 |
) |
|
|
(54,643 |
) |
|
|
(59,744 |
) |
Impairment losses and restructuring/exit cost |
|
|
(6,262 |
) |
|
|
(13,254 |
) |
|
|
(8,226 |
) |
|
|
(37,799 |
) |
Operating income (loss) |
|
|
5,501 |
|
|
|
2,276 |
|
|
|
34,733 |
|
|
|
(10,294 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Share of income (loss) of equity-accounted investees |
|
|
6,682 |
|
|
|
(6 |
) |
|
|
6,681 |
|
|
|
(31 |
) |
Interest expense, net |
|
|
(684 |
) |
|
|
(2,693 |
) |
|
|
(19,173 |
) |
|
|
(13,376 |
) |
Foreign exchange gains (losses), net |
|
|
(691 |
) |
|
|
(1,853 |
) |
|
|
(649 |
) |
|
|
(2,183 |
) |
Income (loss) before income tax expense |
|
|
10,808 |
|
|
|
(2,275 |
) |
|
|
21,592 |
|
|
|
(25,884 |
) |
Tax expense |
|
|
(2,469 |
) |
|
|
(1,951 |
) |
|
|
(11,866 |
) |
|
|
(7,760 |
) |
Net income (loss) |
|
|
8,339 |
|
|
|
(4,226 |
) |
|
|
9,726 |
|
|
|
(33,644 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income attributable to noncontrolling interests |
|
|
1,645 |
|
|
|
3,351 |
|
|
|
8,226 |
|
|
|
5,341 |
|
Net income (loss) attributable to Startek shareholders |
|
|
6,694 |
|
|
|
(7,577 |
) |
|
|
1,500 |
|
|
|
(38,985 |
) |
|
|
|
8,339 |
|
|
|
(4,226 |
) |
|
|
9,726 |
|
|
|
(33,644 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Net income (loss) per common share |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic net income (loss) attributable to Startek shareholders |
|
|
0.16 |
|
|
|
(0.19 |
) |
|
|
0.04 |
|
|
|
(0.99 |
) |
Diluted net income (loss) attributable to Startek shareholders |
|
|
0.16 |
|
|
|
(0.19 |
) |
|
|
0.04 |
|
|
|
(0.99 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
Weighted average common shares outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
||||
Basic |
|
|
40,707 |
|
|
|
40,333 |
|
|
|
40,719 |
|
|
|
39,442 |
|
Diluted |
|
|
40,865 |
|
|
|
40,333 |
|
|
|
41,086 |
|
|
|
39,442 |
|
STARTEK, INC. AND SUBSIDIARIES Condensed Consolidated Balance Sheets (Audited) (In thousands, except share and per share data) |
||||||||
|
|
December 31,
|
December 31,
|
|||||
Assets |
|
|
|
|
|
|||
Current assets |
|
|
|
|
|
|||
Cash and cash equivalents |
|
|
47,940 |
|
|
44,507 |
|
|
Restricted cash |
|
|
7,456 |
|
|
6,052 |
|
|
Trade accounts receivables, net |
|
|
106,937 |
|
|
83,560 |
|
|
Unbilled revenue |
|
|
50,074 |
|
|
49,779 |
|
|
Prepaid and other current assets |
|
|
12,611 |
|
|
14,542 |
|
|
Total current assets |
|
|
225,018 |
|
|
198,440 |
|
|
|
|
|
|
|
|
|||
Non-current assets |
|
|
|
|
|
|||
Property, plant and equipment, net |
|
|
34,168 |
|
|
34,225 |
|
|
Operating lease right-of-use assets |
|
|
63,012 |
|
|
69,376 |
|
|
Intangible assets, net |
|
|
90,092 |
|
|
100,440 |
|
|
Goodwill |
|
|
183,397 |
|
|
183,397 |
|
|
Investment in equity-accounted investees |
|
|
31,688 |
|
|
111 |
|
|
Deferred tax assets, net |
|
|
3,664 |
|
|
5,294 |
|
|
Prepaid expenses and other non-current assets |
|
|
11,436 |
|
|
13,370 |
|
|
Total non-current assets |
|
|
417,457 |
|
|
406,213 |
|
|
Total assets |
|
|
642,475 |
|
|
604,653 |
|
|
|
|
|
|
|
|
|||
Liabilities and Stockholders’ Equity |
|
|
|
|
|
|||
Current liabilities |
|
|
|
|
|
|||
Trade accounts payables |
|
|
11,916 |
|
|
20,074 |
|
|
Accrued expenses |
|
|
53,203 |
|
|
57,118 |
|
|
Short term debt |
|
|
3,611 |
|
|
15,505 |
|
|
Current maturity of long term debt |
|
|
6,241 |
|
|
2,180 |
|
|
Current maturity of operating lease obligation |
|
|
24,393 |
|
|
19,327 |
|
|
Other current liabilities |
|
|
48,265 |
|
|
39,987 |
|
|
Total current liabilities |
|
|
147,629 |
|
|
154,191 |
|
|
|
|
|
|
|
|
|||
Non-current liabilities |
|
|
|
|
|
|||
Long term debt |
|
|
160,175 |
|
|
118,315 |
|
|
Operating lease liabilities |
|
|
44,263 |
|
|
52,052 |
|
|
Other non-current liabilities |
|
|
19,562 |
|
|
15,498 |
|
|
Deferred tax liabilities, net |
|
|
17,526 |
|
|
17,715 |
|
|
Total non-current liabilities |
|
|
241,526 |
|
|
203,580 |
|
|
Total liabilities |
|
|
389,155 |
|
|
357,771 |
|
|
|
|
|
|
|
|
|||
Stockholders’ equity |
|
|
|
|
|
|||
Common stock, 60,000,000 non-convertible shares, $0.01 par value, authorized; 40,893,396 and 40,453,462 shares issued as of December 31, 2021, and December 31, 2020, respectively |
|
|
409 |
|
|
405 |
|
|
Additional paid-in capital |
|
|
291,537 |
|
|
288,700 |
|
|
Accumulated deficit |
|
|
(84,043 |
) |
|
(85,543 |
) |
|
Treasury stock, 412,769 and nil shares as of December 31, 2021, and December 31, 2020, respectively, at cost |
|
|
(1,912 |
) |
|
0 |
|
|
Accumulated other comprehensive loss |
|
|
(10,687 |
) |
|
(7,286 |
) |
|
Equity attributable to Startek shareholders |
|
|
195,304 |
|
|
196,276 |
|
|
Non-controlling interest |
|
|
58,016 |
|
|
50,606 |
|
|
Total stockholders’ equity |
|
|
253,320 |
|
|
246,882 |
|
|
Total liabilities and stockholders’ equity |
|
|
642,475 |
|
|
604,653 |
|
STARTEK, INC. AND SUBSIDIARIES |
Condensed Consolidated Statements of Cash Flows |
(Audited) |
(In thousands, except per share amounts) |
|
Year Ended December 31, |
|||||||
|
2021 |
|
2020 |
|||||
Operating activities |
|
|
|
|
|
|
||
Net income (loss) |
|
|
9,726 |
|
|
|
(33,644 |
) |
|
|
|
|
|
|
|
||
Adjustments to reconcile net income (loss) to net cash generated from operating activities: |
|
|
|
|
|
|
||
Depreciation and amortization |
|
|
28,137 |
|
|
|
28,201 |
|
Impairment of goodwill |
|
|
- |
|
|
|
35,944 |
|
Impairment of right-of-use assets |
|
|
4,514 |
|
|
|
- |
|
Profit on sale of property, plant and equipment |
|
|
(106 |
) |
|
|
167 |
|
Provision for doubtful accounts |
|
|
370 |
|
|
|
2,662 |
|
Amortization of debt issuance costs (including loss on extinguishment of debt) |
|
|
11,607 |
|
|
|
1,454 |
|
Amortization of call option premium |
|
|
1,200 |
|
|
|
- |
|
Warrant contra revenue |
|
|
(87 |
) |
|
|
1,622 |
|
Share-based compensation expense |
|
|
1,418 |
|
|
|
832 |
|
Deferred income taxes |
|
|
1,389 |
|
|
|
(276 |
) |
Share of (income) loss of equity-accounted investees |
|
|
(6,681 |
) |
|
|
31 |
|
|
|
|
|
|
|
|
||
Changes in operating assets and liabilities: |
|
|
|
|
|
|
||
Trade accounts receivables |
|
|
(26,207 |
) |
|
|
19,971 |
|
Prepaid expenses and other assets |
|
|
1,104 |
|
|
|
(11,376 |
) |
Trade accounts payable |
|
|
(7,739 |
) |
|
|
(4,635 |
) |
Income taxes, net |
|
|
3,049 |
|
|
|
2,668 |
|
Accrued expenses and other liabilities |
|
|
7,434 |
|
|
|
22,432 |
|
Net cash generated from operating activities |
|
|
29,128 |
|
|
|
66,053 |
|
|
|
|
|
|
|
|
||
Investing activities |
|
|
|
|
|
|
||
Purchase of property, plant and equipment |
|
|
(17,570 |
) |
|
|
(17,414 |
) |
Investment in equity-accounted investees |
|
|
(25,000 |
) |
|
|
- |
|
Payments for call option premium |
|
|
(3,000 |
) |
|
|
- |
|
Proceeds from equity-accounted investees |
|
|
104 |
|
|
|
395 |
|
Net cash used in investing activities |
|
|
(45,466 |
) |
|
|
(17,019 |
) |
|
|
|
|
|
|
|
||
Financing activities |
|
|
|
|
|
|
||
Proceeds from the issuance of common stock |
|
|
1,510 |
|
|
|
9,026 |
|
Proceeds from long term debt (net of debt issuance cost paid to lenders) |
|
|
156,525 |
|
|
|
- |
|
Payments of long term debt |
|
|
(117,600 |
) |
|
|
(8,400 |
) |
Payments for loan fees related to long term debt |
|
|
(2,794 |
) |
|
|
- |
|
Payments on a line of credit, net |
|
|
- |
|
|
|
(24,529 |
) |
Payments on other debts, net |
|
|
(13,656 |
) |
|
|
(7,304 |
) |
Common stock repurchases |
|
|
(1,912 |
) |
|
|
- |
|
Net cash (used in) generated from financing activities |
|
|
22,073 |
|
|
|
(31,207 |
) |
|
|
|
|
|
|
|
||
Net increase in cash and cash equivalents |
|
|
5,735 |
|
|
|
17,827 |
|
Effect of exchange rate changes on cash and cash equivalents and restricted cash |
|
|
(898 |
) |
|
|
106 |
|
Cash and cash equivalents and restricted cash at the beginning of period |
|
|
50,559 |
|
|
|
32,626 |
|
Cash and cash equivalents and restricted cash at the end of period |
|
|
55,396 |
|
|
|
50,559 |
|
|
|
|
|
|
|
|
||
Components of cash and cash equivalents and restricted cash |
|
|
|
|
|
|
||
Balances with banks |
|
|
47,940 |
|
|
|
44,507 |
|
Restricted cash |
|
|
7,456 |
|
|
|
6,052 |
|
Total cash and cash equivalents and restricted cash |
|
|
55,396 |
|
|
|
50,559 |
|
|
|
|
|
|
|
|
||
Supplemental disclosure of cash flow information |
|
|
|
|
|
|
||
Cash paid for interest and other finance cost |
|
|
22,359 |
|
|
|
13,080 |
|
Cash paid for income taxes |
|
|
7,081 |
|
|
|
4,795 |
|
Noncash warrant contra revenue |
|
|
(87 |
) |
|
|
1,622 |
|
Noncash share-based compensation expenses |
|
|
1,418 |
|
|
|
832 |
|
STARTEK, INC. AND SUBSIDIARIES
RECONCILIATION OF GAAP TO NON-GAAP MEASURES
(In thousands)
(Unaudited)
This press release contains references to the non-GAAP financial measure of Adjusted EBITDA. Reconciliation of this non-GAAP measure to its comparable GAAP measure is included below. This non-GAAP information should not be construed as an alternative to the reported results determined in accordance with GAAP. It is provided solely to assist in an investor’s understanding of these items on the comparability of the Company’s operations.
Adjusted EBITDA:
The Company defines non-GAAP Adjusted EBITDA as Net loss plus Income tax expense, Interest and other expense, net, Depreciation and amortization expense, Restructuring and other acquisition related cost, Share-based compensation expense and Warrant contra revenue (if applicable). Management uses Adjusted EBITDA as a performance measure to analyze the performance of our business. Management believes that excluding these non-cash and other non-recurring items permits a more meaningful comparison and understanding of our strength and performance of our ongoing operations for our investors and analysts.
Adjusted EPS:
Adjusted EPS is a non-GAAP financial measure presenting the earnings generated by our ongoing operations that we believe is useful to investors in making meaningful comparisons to other companies, although our measure of Adjusted EPS may not be directly comparable to similar measures used by other companies, and period-over-period comparisons. Adjusted EPS is defined as our diluted earnings per common share attributable to Startek shareholders adjusted to exclude the effects of the amortization of acquisition-related intangible assets, investments that investors may want to evaluate separately (such as based on fair value) and the impact of certain events, gains, losses or other charges that affect period-over-period comparisons. Acquisition-related intangible assets are recognized as a result of the application of Accounting Standards Codification Topic (“ASC”) 805, Business Combinations (such as customer relationships and Brand), and their amortization is significantly affected by the size and timing of our acquisitions.
Adjusted EBITDA: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December |
|
|
Year Ended December 31, |
|||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Net income (loss) |
|
|
8,339 |
|
|
|
(4,226 |
) |
|
|
9,726 |
|
|
|
(33,644 |
) |
Income tax expense |
|
|
2,469 |
|
|
|
1,951 |
|
|
|
11,866 |
|
|
|
7,760 |
|
Interest and other expense, net |
|
|
(5,998 |
) |
|
|
2,699 |
|
|
|
12,492 |
|
|
|
13,407 |
|
Foreign exchange gains (losses), net |
|
|
691 |
|
|
|
1,853 |
|
|
|
649 |
|
|
|
2,183 |
|
Depreciation and amortization expense |
|
|
7,739 |
|
|
|
6,922 |
|
|
|
28,137 |
|
|
|
28,201 |
|
Impairment losses and restructuring cost |
|
|
6,262 |
|
|
|
13,254 |
|
|
|
8,226 |
|
|
|
37,799 |
|
Share-based compensation expense |
|
|
486 |
|
|
|
385 |
|
|
|
1,418 |
|
|
|
832 |
|
Warrant contra revenue |
|
|
(1,078 |
) |
|
|
449 |
|
|
|
(87 |
) |
|
|
1,622 |
|
Adjusted EBITDA |
|
|
18,910 |
|
|
|
23,287 |
|
|
|
72,427 |
|
|
|
58,160 |
|
Adjusted EPS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended December |
|
|
Year Ended December 31, |
|||||||||||
|
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Income (loss) attributable to Startek shareholders |
|
|
6,694 |
|
|
|
(7,577 |
) |
|
|
1,500 |
|
|
|
(38,985 |
) |
Add: Share based compensation expense |
|
|
486 |
|
|
|
385 |
|
|
|
1,418 |
|
|
|
832 |
|
Add: Amortization of intangible assets, net of tax |
|
|
2,277 |
|
|
|
2,277 |
|
|
|
9,062 |
|
|
|
9,078 |
|
Add: Warrant contra revenue |
|
|
(1,078 |
) |
|
|
449 |
|
|
|
(87 |
) |
|
|
1,622 |
|
Add: Impairment of right-of-use assets |
|
|
4,514 |
|
|
|
- |
|
|
|
4,514 |
|
|
|
- |
|
Add: Goodwill impairment loss |
|
|
- |
|
|
|
13,236 |
|
|
|
- |
|
|
|
35,944 |
|
Add: Debt issuance cost |
|
|
- |
|
|
|
- |
|
|
|
10,937 |
|
|
|
- |
|
Adjusted net income (loss) - (non-GAAP) |
|
|
12,893 |
|
|
|
8,770 |
|
|
|
27,343 |
|
|
|
8,491 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average common shares outstanding - Basic |
|
|
40,707 |
|
|
|
40,333 |
|
|
|
40,719 |
|
|
|
39,442 |
|
Weighted average common shares outstanding - Diluted |
|
|
40,865 |
|
|
|
40,333 |
|
|
|
41,086 |
|
|
|
39,442 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EPS - Basic |
|
|
0.32 |
|
|
|
0.22 |
|
|
|
0.67 |
|
|
|
0.22 |
|
Adjusted EPS - Diluted |
|
|
0.32 |
|
|
|
0.22 |
|
|
|
0.67 |
|
|
|
0.22 |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20220310005716/en/